Shots:

• Soliton to receive $22.60 /share in cash for its all outstanding share making the total deal value $550M
• The acquisition adds Soliton’s Rapid Acoustic Pulse technology platform to Allergan Aesthetics’s portfolio for improvement in appearance of cellulite in the buttocks and thighs by using rapid high-frequency sound waves to disrupt targeted cellular structures and connective tissue
• The technology complements Allergan Aesthetics' portfolio of body contouring treatments includes CoolSculpting Elite. Resonic has received FDA clearance for tattoo removal in conjunction with laser and has demonstrated clinical results in fibrotic scars

  Ref: PRNewswire | Image: PRNewswire